Back to Results

D419NC00001 A Phase 1/2 Study of Durvalumab and Monalizumab in Adult Subjects with Select Advanced Solid Tumors

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Phase

I - Research Studies that focus on the safety of a drug. The goal is to determine the drug's most frequent and serious adverse events and, often, how the drug is broken down and excreted by the body. These studies usually involve a small number of participants.

Type of Study

Treatment

Scope

National

Location

University of Colorado Hospital

Principal Investigator
Jennifer Diamond,  MD

Jennifer Diamond, MD

Study ID

Protocol Number: 16-0207

ClinicalTrials.gov: NCT02671435

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers